Mylotarg and ascites Patient Reports February 12, 2012

Mylotarg Side Effects Report #5353522-3
Mylotarg side effect was reported by a Pharmacist from UNITED STATES on June 08, 2007. Male patient, 67 years of age, weighting 234.0 lb, was diagnosed with leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal pain , alanine aminotransferase increased, ascites, asthenia, blood bilirubin increased, fatigue, hypotension, neutropenia, portal vein thrombosis. Mylotarg dosage: 20MG EA. DOSE -14-DAYS APART- Q14 DAYS IV. Patient died on 09/01/2006.

Mylotarg Side Effects Report #5059006-4
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on July 10, 2006. Female patient, 63 years of age, weighting 108.0 lb, was diagnosed with chronic myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal tenderness, activated partial thromboplastin time prolonged, alanine aminotransferase increased, ascites, aspartate aminotransferase increased, blood albumin decreased, blood alkaline phosphatase increased, blood bilirubin increased. Mylotarg dosage: 13 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, GEMCITABINE, NOVANTRONE, DIFLUCAN, DILAUDID, ATIVAN, LEVAQUIN, INSULIN. Patient was hospitalized. Patient died on 04/02/2003.

Mylotarg Side Effects Report #5123334-4
Mylotarg side effect was reported by a Health Professional from JAPAN on Sept 25, 2006. Female patient, 78 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, ascites, aspartate aminotransferase increased, blood alkaline phosphatase increased, conjunctival haemorrhage, febrile neutropenia, haematuria, hepatomegaly. Mylotarg dosage: unknown. During the same period patient was treated with AMLODIPINE BESYLATE, LOSARTAN POTASSIUM, SULFAMETHOXAZOLE, FLUCONAZOLE, FAMOTIDINE, MUCOSTA, POLYMYXIN B SULPHATE. Patient recovered.

Mylotarg Side Effects Report #4949329-9
Mylotarg side effect was reported by a Physician from UNITED STATES on Mar 07, 2006. Male patient, 73 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: ascites, hepatotoxicity, weight increased. Mylotarg dosage: unknown. Patient recovered.


Mylotarg Side Effects Report #4869570-3
Mylotarg side effect was reported by a Consumer or non-health professional from TURKEY on Dec 20, 2005. Female patient, 68 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: ascites, budd-chiari syndrome, diarrhoea, febrile neutropenia, hepatomegaly, lower gastrointestinal haemorrhage, respiratory tract infection fungal. Mylotarg dosage: unknown. Patient recovered.

Mylotarg Side Effects Report #4928140-9
Mylotarg side effect was reported by a Health Professional from JAPAN on Feb 09, 2006. Male patient, 59 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: ascites, dehydration, hepatitis , hiccups, interstitial lung disease, venoocclusive liver disease, viral infection , weight increased. Mylotarg dosage: 16 MG (9 MG/M2/DAY) INTRAVENOUS DRIP. During the same period patient was treated with MEROPEN, AMIKACIN SULPHATE, FUNGUARD, LEUKOPROL. Patient recovered.

Mylotarg Side Effects Report #4951016-8
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Mar 02, 2006. Male patient, 59 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal pain , anorexia, ascites, dehydration, hepatitis , hiccups, interstitial lung disease, leukaemic infiltration hepatic, neutropenic infection. Mylotarg dosage: 16 MG (9 MG/M2/DAY); INTRAVENOUS DRIP. During the same period patient was treated with MEROPEN, AMIKACIN SULPHATE, FUNGUARD, LEUKOPROL, TIENAM, OZEK, SULFAMETHOXAZOLE, ITRACONAZOLE. Patient recovered.

Mylotarg Side Effects Report #5251332-9
Mylotarg side effect was reported by a Physician from JAPAN on Feb 19, 2007. Male patient, weighting 154.3 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, ascites, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, hepatomegaly, leucine aminopeptidase increased, neutrophil count decreased, platelet count decreased. Mylotarg dosage: unknown. During the same period patient was treated with MAXIPIME, AMIKACIN SULPHATE, TIENAM, CIPROFLOXACIN, OMEPRAL, MEROPENEM. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5253016-X
Mylotarg side effect was reported by a Physician from JAPAN on Feb 19, 2007. Male patient, weighting 154.3 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, ascites, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, hepatomegaly, leucine aminopeptidase increased, neutrophil count decreased, platelet count decreased. Mylotarg dosage: unknown. During the same period patient was treated with MAXIPIME, AMIKACIN SULPHATE, TIENAM, CIPROFLOXACIN, OMEPRAL, MEROPENEM. Patient was hospitalized. Patient recovered.


Mylotarg Side Effects Report #5280107-X
Mylotarg side effect was reported by a Physician from JAPAN on Mar 20, 2007. Female patient, weighting 134.5 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, ascites, febrile neutropenia, hepatomegaly, malaise, neutrophil count decreased, platelet count decreased, weight increased. Mylotarg dosage: unknown. During the same period patient was treated with POLYMYXIN B SULPHATE, FLUCONAZOLE, FAMOTIDINE, MUCOSTA, AMLODIN, BAKTAR. Patient recovered.

Mylotarg Side Effects Report #5291882-2
Mylotarg side effect was reported by a Physician from JAPAN on Mar 29, 2007. Male patient, weighting 154.3 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, ascites, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, hepatomegaly, leucine aminopeptidase increased, neutrophil count decreased, platelet count decreased. Mylotarg dosage: unknown. During the same period patient was treated with HYDROCORTISONE SUCCINATE. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5303031-2
Mylotarg side effect was reported by a Physician from JAPAN on Apr 13, 2007. Male patient, weighting 152.1 lb, was diagnosed with acute myeloid leukaemia recurrent, hyperlipidaemia, diabetes mellitus, constipation , prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal distension, agranulocytosis, ascites, atelectasis, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, chest x-ray abnormal, cholestasis. Mylotarg dosage: unknown. During the same period patient was treated with LIPITOR, ACTOS, MAGNESIUM OXIDE, HUMULIN, BACTRIM, POLYMYXIN B SULPHATE, FUNGIZONE. Patient was hospitalized. Patient died on 01/18/2007.

Mylotarg Side Effects Report #5315496-0
Mylotarg side effect was reported by a Physician from JAPAN on Apr 24, 2007. Male patient, weighting 154.3 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, ascites, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, blood urea increased, chills. Mylotarg dosage: unknown. During the same period patient was treated with HYDROCORTISONE SUCCINATE. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5343683-4
Mylotarg side effect was reported by a Physician from JAPAN on May 25, 2007. Male patient, weighting 154.3 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, ascites, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, hepatomegaly, leucine aminopeptidase increased, neutrophil count decreased, platelet count decreased. Mylotarg dosage: unknown. During the same period patient was treated with HYDROCORTISONE SUCCINATE. Patient was hospitalized. Patient recovered.


Mylotarg Side Effects Report #5822128-1
Mylotarg side effect was reported by a Physician from JAPAN on July 16, 2008. Male patient, weighting 154.3 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, ascites, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, hepatomegaly, hypoalbuminaemia. Mylotarg dosage: unknown. During the same period patient was treated with HYDROCORTISONE SUCCINATE. Patient was hospitalized. Patient died on 12/09/2007.

Mylotarg Side Effects Report #5971499-4
Mylotarg side effect was reported by a Physician from JAPAN on Nov 19, 2008. Male patient, weighting 154.3 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, ascites, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, hepatomegaly, hypoalbuminaemia. Mylotarg dosage: unknown. During the same period patient was treated with HYDROCORTISONE SUCCINATE. Patient was hospitalized. Patient died on 12/09/2007.

Mylotarg Side Effects Report #6054475-5
Mylotarg side effect was reported by a Physician from JAPAN on Jan 21, 2009. Male patient, weighting 154.3 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, ascites, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, hepatomegaly, hypoalbuminaemia. Mylotarg dosage: unknown. During the same period patient was treated with HYDROCORTISONE SUCCINATE. Patient was hospitalized. Patient died on 12/09/2007.

Mylotarg Side Effects Report #5093595-9
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 17, 2006. Male patient, 78 years of age, weighting 139.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal discomfort, acute myeloid leukaemia, ascites, blood calcium decreased, blood potassium decreased, blood urea increased, disease progression, febrile neutropenia, haematemesis. Mylotarg dosage: 15 MG ONE TIME PER ONE DOSE, INTRAVENOUS. During the same period patient was treated with ACETAMINOPHEN, DOCUSATE, DIPHENHYDRAMINE, HYDROXYUREA, ALLOPURINOL, TRAZODONE, PERCOCET, SEREVENT. Patient was hospitalized. Patient died on 04/26/2002.

Mylotarg Side Effects Report #4951697-9
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Male patient, 78 years of age, weighting 139.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal discomfort, acute myeloid leukaemia, ascites, blood potassium decreased, blood urea increased, blood uric acid increased, decreased appetite, febrile neutropenia, haematemesis. Mylotarg dosage: 15 MG ONE TIME PER ONE DOSE INTRAVENOUS. During the same period patient was treated with ACETAMINOPHEN, DOCUSATE, DIPHENHYDRAMINE, HYDROXYUREA, ALLOPURINOL, TRAZODONE, PERCOCET, SEREVENT. Patient was hospitalized. Patient died on 04/26/2002.


Mylotarg Side Effects Report #5110577-9
Mylotarg side effect was reported by a Physician from UNITED STATES on Sept 08, 2006. Male patient, 76 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal distension, ascites, bacteraemia, blood bilirubin increased, blood product transfusion dependent, clostridium difficile colitis, hepatomegaly, jaundice . Mylotarg dosage: 6 MG/M^2 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with CYTARABINE. Patient died on 09/10/2006.

Mylotarg Side Effects Report #4952734-8
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on July 20, 2004. Male patient, 76 years of age, weighting 198.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acidosis, ascites, condition aggravated, dialysis , enterococcal infection, hepatomegaly, hypotension, liver function test abnormal, renal failure. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with NPH INSULIN, MEROPENEM, MORPHINE SULPHATE, PHENERGAN, DARVON, URSODIOL, VANCOMYCIN. Patient was hospitalized. Patient died on 11/19/2003.

Mylotarg Side Effects Report #5041922-0
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on June 21, 2006. Male patient, 76 years of age, weighting 189.6 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain , ascites, aspartate aminotransferase increased, blood albumin decreased, blood creatinine increased, blood urea increased, haemoglobin decreased, platelet count decreased. Mylotarg dosage: 18 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with FLAGYL, ACETAMINOPHEN, ZOVIRAX, NORVASC, ROCEPHIN, LOPRESSOR, PROTONIX, VORICONAZOLE. Patient recovered.

Mylotarg Side Effects Report #5085880-1
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 07, 2006. Male patient, 75 years of age, weighting 163.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: ascites, blood bilirubin increased, body temperature increased, cholelithiasis, febrile neutropenia, fluid retention, hepatomegaly, liver tenderness, pancytopenia. Mylotarg dosage: unknown. During the same period patient was treated with PREDNISONE, LEVOXYL, DYAZIDE, CELEBREX, RESTORIL. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4696392-9
Mylotarg side effect was reported by a Consumer or non-health professional from on June 08, 2005. Male patient, 75 years of age, weighting 240.5 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: ascites, bacillus infection, biliary dilatation, blood calcium decreased, blood potassium decreased, candidiasis, cholelithiasis, disease progression, dyspnoea exertional. Mylotarg dosage: 20 MG 1X PER 1 DAY; INTRAVENOUS. Patient was hospitalized. Patient died on 08/09/2004.


Mylotarg Side Effects Report #4958840-6
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Mar 15, 2006. Male patient, 74 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, ascites, blood potassium decreased, disease progression, fatigue, febrile neutropenia, hyperkalaemia, pleural effusion, pulmonary oedema. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, ACLARUBICIN HYDROCHLORIDE. Patient was hospitalized and became disabled. Patient recovered.

Mylotarg Side Effects Report #4998575-7
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Apr 24, 2006. Male patient, 74 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, ascites, blood urea increased, body temperature increased, disease progression, fatigue, febrile neutropenia, hyperkalaemia, pleural effusion. Mylotarg dosage: 9 MG/M^2 1 PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, ACLARUBICIN HYDROCHLORIDE. Patient was hospitalized. Patient died.

Mylotarg Side Effects Report #5047652-3
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on June 29, 2006. Female patient, 73 years of age, weighting 114.6 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: ascites, blood chloride increased, blood glucose increased, cardiomegaly, catheter related infection, disease progression, dyspnoea, febrile neutropenia, haemoglobin decreased. Mylotarg dosage: 17 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with PREDNISONE, PREVACID, SENOKOT, VITAMINS NOS, ZOSYN, DIFLUCAN, LEVAQUIN. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5073616-X
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on July 28, 2006. Female patient, 73 years of age, weighting 114.6 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: ascites, blood alkaline phosphatase increased, blood calcium decreased, blood chloride increased, blood creatine increased, blood creatine phosphokinase increased, blood lactate dehydrogenase increased, blood phosphorus decreased, blood potassium decreased. Mylotarg dosage: 17 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with PREDNISONE, PREVACID, SENOKOT, VITAMINS NOS, ZOSYN, DIFLUCAN, LEVAQUIN. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5127211-4
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 27, 2006. Female patient, 73 years of age, weighting 114.6 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: ascites, blast cell count increased, blood alkaline phosphatase increased, blood calcium decreased, blood chloride increased, blood creatinine increased, blood glucose decreased, blood glucose increased, blood lactate dehydrogenase increased. Mylotarg dosage: 17 MG 1X PER 1 DAY; INTRAVENOUS. During the same period patient was treated with PREDNISONE, PREVACID, SENOKOT, VITAMINS NOS, ZOSYN, DIFLUCAN, LEVAQUIN. Patient was hospitalized. Patient recovered.


Mylotarg Side Effects Report #4802759-8
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 03, 2005. Female patient, 73 years of age, weighting 114.6 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: ascites, blood glucose increased, cardiomegaly, central line infection, chills, disease progression, dyspnoea, febrile neutropenia, haematocrit decreased. Mylotarg dosage: 17 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with PREDNISONE, PREVACID, SENOKOT, VITAMINS NOS, ZOSYN, DIFLUCAN, LEVAQUIN. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4949574-2
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 07, 2006. Female patient, 73 years of age, weighting 114.6 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: ascites, central line infection, chills, disease progression, dyspnoea, febrile neutropenia, haematocrit decreased, haemoglobin decreased, infusion related reaction. Mylotarg dosage: 17 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with PREDNISONE, PREVACID, SENOKOT, VITAMINS NOS, ZOSYN, DIFLUCAN, LEVAQUIN. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4967137-X
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 22, 2006. Male patient, 73 years of age, weighting 134.5 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, ascites, disease progression, hepatic failure, hepatomegaly, malaise, pleural effusion, renal failure acute, splenomegaly. Mylotarg dosage: 15.3 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with ACYCLOVIR, ATENOLOL, FUROSEMIDE, FLUCONAZOLE, LISINOPRIL, POTASSIUM CHLORIDE, NITROGLYCERIN TRANSDERMAL SYSTEM. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5052858-3
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on June 29, 2006. Male patient, 70 years of age, weighting 198.4 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, ascites, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase, bone marrow transplant , chills, dehydration. Mylotarg dosage: 18.9 MG 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient died on 01/08/2006.

Mylotarg Side Effects Report #5056539-1
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on July 11, 2006. Male patient, 70 years of age, weighting 198.4 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, ascites, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, bone marrow transplant , chills. Mylotarg dosage: 18.9 MG 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient died on 01/08/2006.


Mylotarg Side Effects Report #4986553-3
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 11, 2006. Male patient, 70 years of age, weighting 198.4 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, ascites, chills, disease progression, dizziness , dyspnoea, febrile neutropenia, fluid overload. Mylotarg dosage: 18.9 MG 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient died on 01/08/2006.

Mylotarg Side Effects Report #4744368-5
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on July 25, 2005. Male patient, 69 years of age, weighting 179.9 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, ascites, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, pyrexia, weight increased. Mylotarg dosage: unknown. Patient recovered.

Mylotarg Side Effects Report #4949824-2
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Male patient, 69 years of age, weighting 169.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute prerenal failure, ascites, haemoglobin decreased, hepatic failure, herpes simplex , infusion related reaction, mucosal inflammation, neutropenic sepsis, platelet count decreased. Mylotarg dosage: 17 MG 1X PER 1 DAY, INTRAVENOUS : 15 MG 1X PER 1 DAY , INTRAVENOUS. Patient was hospitalized. Patient died on 04/28/2004.

Mylotarg Side Effects Report #4952627-6
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Male patient, 69 years of age, weighting 179.9 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, angiopathy, ascites, aspartate aminotransferase increased, blood bilirubin increased, gallbladder disorder, infusion related reaction, liver disorder, liver function test abnormal. Mylotarg dosage: unknown. Patient recovered.

Mylotarg Side Effects Report #4973906-2
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 29, 2006. Male patient, 69 years of age, weighting 276.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: ascites, atelectasis, chills, cholelithiasis, dry mouth, dyspnoea, failure to thrive, fatigue, feeling abnormal. Mylotarg dosage: 21 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with DIPHENHYDRAMINE, ACETAMINOPHEN. Patient was hospitalized. Patient died on 05/06/2004.


Mylotarg Side Effects Report #4681377-9
Mylotarg side effect was reported by a Consumer or non-health professional from on May 19, 2005. Female patient, 68 years of age, weighting 161.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: ascites, aspartate aminotransferase increased, bacteraemia, blood alkaline phosphatase increased, blood bilirubin increased, chills, decreased appetite, dyspnoea, enterobacter infection. Mylotarg dosage: 12 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with CYTARABINE, ACYCLOVIR, PROTONIX. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4867670-5
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 01, 2005. Male patient, 65 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia recurrent, agitation, arthralgia, ascites, aspergillosis, atelectasis, bacteria blood identified, bacterial infection , candidiasis. Mylotarg dosage: 9 MG/M(2), INTRAVENOUS. During the same period patient was treated with SYNTHROID, LOTREL, EFFEXOR, VOLTAREN, DIFLUCAN, CIPRO, CARAFATE. Patient was hospitalized. Patient died on 12/21/1998.

Mylotarg Side Effects Report #5127210-2
Mylotarg side effect was reported by a Physician from UNITED STATES on Sept 27, 2006. Male patient, 60 years of age, weighting 180.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal pain lower, abscess , anorexia, ascites, blood alkaline phosphatase increased, chills, diplopia, diverticulitis, diverticulum. Mylotarg dosage: 18 MG 1X PER 1 DAY; INTRAVENOUS. During the same period patient was treated with DIFLUCAN, VALTREX, PREVACID, SOTALOL HYDROCHLORIDE, LEVAQUIN, ANUSOL, CITRACAL, DILAUDID. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4948798-8
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Male patient, 60 years of age, weighting 287.5 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, ascites, aspartate aminotransferase increased, blood bilirubin increased, blood pressure increased, dialysis , disease progression, hepatic steatosis. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with INSULIN, ACYCLOVIR, ALLOPURINOL, NORVASC, FIBRALAX, CIPROFLOXACIN, KLONOPIN. Patient was hospitalized. Patient died on 11/01/2003.

Mylotarg Side Effects Report #4952727-0
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on July 30, 2004. Male patient, 60 years of age, weighting 180.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal pain lower, abscess , anorexia, ascites, blood alkaline phosphatase increased, blood culture positive, diplopia, febrile neutropenia, gamma-glutamyltransferase increased. Mylotarg dosage: 18 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with DIFLUCAN, VALTREX, PREVACID, SOTALOL, ANUSOL, CITRACAL, DILAUDID, AMBIEN. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5006870-0
Mylotarg side effect was reported by a Health Professional from UNITED STATES on May 05, 2006. Female patient, 60 years of age, weighting 163.8 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: ascites, venoocclusive liver disease. Mylotarg dosage: A SINGLE 11 MG DOSE, INTRAVENOUS. Patient recovered.

Mylotarg Side Effects Report #5047777-2
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on June 26, 2006. Male patient, 60 years of age, weighting 180.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal pain lower, abscess , anorexia, ascites, blood alkaline phosphatase increased, chills, diplopia, diverticulitis, febrile neutropenia. Mylotarg dosage: 18 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with DUFLUCAN, VALTREX, PREVACID, SOTALOL, LEVAQUIN, ANUSOL, CITRACAL, DILAUDID. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4941833-2
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 24, 2006. Female patient, 58 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: ascites, aspergillosis, bacteria urine identified, blood culture positive, clostridium colitis, culture urine positive, febrile neutropenia, fungal infection , hepatic vein stenosis. Mylotarg dosage: unknown. Patient was hospitalized. Patient died on 11/08/2005.

Mylotarg Side Effects Report #4967481-6
Mylotarg side effect was reported by a Health Professional from UNITED STATES on Mar 22, 2006. Female patient, 58 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, ascites, bacteria urine identified, blood culture positive, chills, clostridium colitis, cough, effusion, febrile neutropenia. Mylotarg dosage: unknown. Patient was hospitalized. Patient died on 11/08/2005.

Mylotarg Side Effects Report #4725790-X
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on July 14, 2005. Male patient, 57 years of age, weighting 206.8 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: ascites, hyperbilirubinaemia. Mylotarg dosage: unknown. During the same period patient was treated with CYTARABINE. Patient recovered.


Mylotarg Side Effects Report #4766562-X
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 30, 2005. Male patient, 57 years of age, weighting 206.8 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: ascites, hyperbilirubinaemia. Mylotarg dosage: 13.2 MG 1X PER 1 DAY, INTRAVENOUS; 8.8 MG 1X [ER 1 DAY, INTRAVENOUS. During the same period patient was treated with CYTARABINE. Patient recovered.

Mylotarg Side Effects Report #5105237-4
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 29, 2006. Female patient, 56 years of age, weighting 189.8 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal pain , alanine aminotransferase increased, ascites, aspartate aminotransferase increased, blood albumin decreased, blood alkaline phosphatase increased, blood bilirubin increased, hepatic function abnormal, neutropenic sepsis. Mylotarg dosage: 10.7 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with VANCOMYCIN, LEVOFLOXACIN, ACYCLOVIR, POTASSIUM CHLORIDE, LORAZEPAM, BICARBONATE IN PLASTIC CONTAINER, CHLORIDE, FLUCONAZOLE. Patient died on 09/20/2004.

Mylotarg Side Effects Report #5071751-3
Mylotarg side effect was reported by a Physician from UNITED STATES on July 24, 2006. Male patient, 55 years of age, weighting 202.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: ascites, hepatomegaly, pleural effusion, portal vein thrombosis. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with BENADRYL, ZOFRAN, ACYCLOVIR, AVELOX, CELLCEPT. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5136054-7
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 10, 2006. Female patient, 55 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: ascites, febrile neutropenia, pleural effusion, pneumonia , venoocclusive liver disease, weight increased. Mylotarg dosage: 9.3 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with VORICONAZOLE, VANCOMYCIN, LEVOFLOXACIN, CEFEPIME, POTASSIUM CHLORIDE, NEUPOGEN, DEXAMETHASONE, METRONIDAZOLE. Patient recovered.

Mylotarg Side Effects Report #5128909-4
Mylotarg side effect was reported by a Physician from UNITED STATES on Sept 29, 2006. Male patient, 51 years of age, weighting 153.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: ascites, blood alkaline phosphatase increased, blood bilirubin increased, cardiac failure congestive, dilatation atrial, dilatation ventricular, febrile neutropenia, fluid retention, gallbladder disorder. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with ACYCLOVIR, FLUCONAZOLE. Patient was hospitalized. Patient died on 08/04/2003.

Mylotarg Side Effects Report #4653739-7
Mylotarg side effect was reported by a Consumer or non-health professional from on Apr 22, 2005. Male patient, 51 years of age, weighting 195.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, ascites, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood culture positive, condition aggravated, febrile neutropenia, renal failure acute. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY. During the same period patient was treated with ABELCET, SPORANOX, REMERON, ACYCLOVIR, VITAMINS, VICODIN. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4757067-0
Mylotarg side effect was reported by a Health Professional from UNITED STATES on Aug 18, 2005. Male patient, 51 years of age, weighting 153.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: ascites, blast cell proliferation, body temperature decreased, cardiac failure congestive, dilatation atrial, febrile neutropenia, haematocrit decreased, haemoglobin decreased, interstitial lung disease. Mylotarg dosage: 9 MG/M^2 1X PER 1DAY, INTRAVENOUS. During the same period patient was treated with ACYCLOVIR, FLUCONAZOLE. Patient was hospitalized. Patient died on 08/04/2003.

Mylotarg Side Effects Report #4831548-3
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 03, 2005. Male patient, 51 years of age, weighting 195.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: ascites, febrile neutropenia, liver function test abnormal, renal failure acute, staphylococcal bacteraemia. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY. During the same period patient was treated with ABELCET, SPORANOX, REMERON, ACYCLOVIR, VITAMINS, VICODIN. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5032225-9
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on June 06, 2006. Male patient, 51 years of age, weighting 195.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, ascites, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, condition aggravated, febrile neutropenia, liver function test abnormal, renal failure acute. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY. During the same period patient was treated with ABELCET, SPORANOX, REMERON, ACYCLOVIR, VITAMINS, VICODIN. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4949582-1
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 07, 2006. Female patient, 50 years of age, weighting 129.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: ascites, atelectasis, blood creatinine increased, blood urea increased, disease progression, disseminated intravascular coagulation, haemoglobin decreased, hypoalbuminaemia, hypotension. Mylotarg dosage: 15 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with BACTRIM DS, ADVAIR DISKUS, ALPHAGAN, ATROVENT, PROVENTIL, PROTONIX, AMBIEN, VITAMINS. Patient was hospitalized. Patient died on 10/02/2003.


Mylotarg Side Effects Report #4870056-0
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 20, 2005. Female patient, 46 years of age, weighting 148.4 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal pain upper, alanine aminotransferase increased, ascites, aspartate aminotransferase increased, beta haemolytic streptococcal infection, blood alkaline phosphatase increased, blood bilirubin increased, body temperature increased, computerised tomogram abnormal. Mylotarg dosage: 15 MG 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5147885-1
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 25, 2006. Female patient, 45 years of age, weighting 119.6 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: ascites, aspartate aminotransferase increased, atelectasis, caecitis, clostridium difficile colitis, constipation , dyspnoea, hypocalcaemia, hypoglycaemia. Mylotarg dosage: 6 MG/M^2 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with CYTARABINE, DAUNORUBICIN. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4730080-5
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on July 25, 2005. Female patient, 45 years of age, weighting 174.8 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: ascites, aspartate aminotransferase increased, biliary tract disorder, blood bilirubin increased, cardiac failure congestive, cardiomegaly, cryptogenic organizing pneumonia, dizziness , febrile neutropenia. Mylotarg dosage: 15 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with CYTARABINE. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4949081-7
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Female patient, 45 years of age, weighting 174.8 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: ascites, aspartate aminotransferase increased, biliary tract disorder, blood bilirubin increased, cardiac failure congestive, cardiomegaly, chills, cryptogenic organizing pneumonia, dizziness . Mylotarg dosage: 15 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with CYTARABINE. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4952755-5
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on June 23, 2004. Male patient, 45 years of age, weighting 160.9 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal pain upper, ascites, blood alkaline phosphatase increased, gastrointestinal haemorrhage, haematocrit decreased, haemoglobin decreased, hepatic failure, jaundice , melaena. Mylotarg dosage: 16.2 MG X1 PER 1 DAY, INTRAVENOUS. During the same period patient was treated with LEVAQUIN, DIFLUCAN, BACTRIM, PROGRAF, ACYCLOVIR, TYLENOL W, SPORANOX. Patient was hospitalized. Patient died on 06/26/2002.

Mylotarg Side Effects Report #4948799-X
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Male patient, 37 years of age, weighting 152.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain upper, abdominal rigidity, ascites, bowel sounds abnormal, febrile neutropenia, gallbladder disorder, hepatomegaly, infusion related reaction. Mylotarg dosage: 10 MG 1X PER 1 DAY, INTRAVENOUS; 7 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with PANTOPRAZOLE, VITAMINS, THIAMINE, FOLIC ACID, TRAZODONE, NICOTINE, ACYCLOVIR. Patient recovered.

Mylotarg Side Effects Report #4562287-4
Mylotarg side effect was reported by a Consumer or non-health professional from on Jan 13, 2005. Female patient, 24 years of age, weighting 194.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, ascites, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, epistaxis, gallbladder disorder, hepatomegaly, hyperbilirubinaemia. Mylotarg dosage: 18 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with VORICONAZOLE, VANCOMYCIN, VALTREX. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4732444-2
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on July 21, 2005. Female patient, 24 years of age, weighting 194.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal pain upper, alanine aminotransferase increased, ascites, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, chromaturia, epistaxis, fatigue. Mylotarg dosage: 18 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with TYLENOL, VORICONAZOLE, VANCOMYCIN, VALTREX. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #4790494-4
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 11, 1998. Female patient, 24 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal distension, alanine aminotransferase increased, ascites, aspartate aminotransferase increased, blood bilirubin increased, blood creatinine increased, cardiac output decreased, chills, confusional state. Mylotarg dosage: 9 MG/M (2), INTRAVENOUS. During the same period patient was treated with ABELCET. Patient was hospitalized. Patient died on 11/09/1998.

Mylotarg Side Effects Report #4801401-X
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 11, 1998. Female patient, 24 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, ascites, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood creatinine increased, blood urea increased, confusional state, dialysis , dizziness . Mylotarg dosage: 9 MG /M (2), INTRAVENOUS. During the same period patient was treated with ABELCET. Patient was hospitalized. Patient died on 11/09/1998.


Mylotarg Side Effects Report #4867671-7
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 13, 2002. Female patient, 24 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal distension, acidosis, anaemia, ascites, bowel sounds abnormal, chills, confusional state, cyanosis, dialysis . Mylotarg dosage: 9 MG/M(2), INTRAVENOUS. During the same period patient was treated with ABELCET. Patient was hospitalized. Patient died on 11/09/1998.

Mylotarg Side Effects Report #4867697-3
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 28, 1998. Female patient, 24 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: ascites, aspartate aminotransferase increased, chills, haemoglobin decreased, heart rate decreased, heart rate increased, hypoxia, platelet count decreased, sepsis . Mylotarg dosage: 9 MG/SQ.M, INTRAVENOUS. During the same period patient was treated with TYLENOL, BENADRYL. Patient died on 11/09/1998.

Mylotarg Side Effects Report #4973909-8
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 28, 2006. Female patient, 24 years of age, weighting 194.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal pain upper, alanine aminotransferase increased, ascites, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, body temperature increased, epistaxis, fatigue. Mylotarg dosage: 18 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with TYLENOL, VORICONAZOLE, VANCOMYCIN, VALTREX. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5141357-6
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 30, 2006. Female patient, weighting 119.6 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: ascites, aspartate aminotransferase increased, atelectasis, caecitis, clostridial infection, constipation , dyspnoea, hyperglycaemia, hypocalcaemia. Mylotarg dosage: 9.5 MG. During the same period patient was treated with CYTARABINE, DAUNORUBICIN. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5368772-X
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on June 21, 2007. Male patient, weighting 257.9 lb, was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal pain , activated partial thromboplastin time prolonged, alanine aminotransferase increased, ascites, aspartate aminotransferase increased, blood bilirubin increased, blood lactate dehydrogenase increased, coagulopathy, fibrin d dimer increased. Mylotarg dosage: 13.8 MG. During the same period patient was treated with CYTARABINE, DAUNORUBICIN. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5451361-6
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 11, 2007. Female patient, weighting 134.7 lb, was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal distension, ascites, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, renal failure, renal failure acute, ultrasound doppler abnormal, venoocclusive disease. Mylotarg dosage: 9 MG. Patient recovered.

Mylotarg Side Effects Report #5469452-2
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 25, 2007. Female patient, weighting 134.7 lb, was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal distension, acute myeloid leukaemia, alanine aminotransferase increased, ascites, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, renal failure acute, transplant. Mylotarg dosage: 9 MG. During the same period patient was treated with DAUNORUBICIN, CYTARABINE. Patient recovered.